Astera Labs, Inc. $ALAB Shares Sold by Virtus Wealth Solutions LLC

Virtus Wealth Solutions LLC trimmed its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 49.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,942 shares of the company’s stock after selling 40,223 shares during the quarter. Astera Labs makes up about 1.5% of Virtus Wealth Solutions LLC’s portfolio, making the stock its 17th biggest holding. Virtus Wealth Solutions LLC’s holdings in Astera Labs were worth $8,016,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in ALAB. Vanguard Group Inc. increased its holdings in Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. State Street Corp boosted its stake in shares of Astera Labs by 39.3% during the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after acquiring an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. grew its position in shares of Astera Labs by 151.4% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after acquiring an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Astera Labs by 46.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after acquiring an additional 479,360 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Astera Labs by 36.2% in the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock valued at $112,562,000 after purchasing an additional 330,841 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Trading Down 0.2%

Shares of NASDAQ ALAB opened at $128.15 on Thursday. The stock has a market cap of $21.81 billion, a PE ratio of 105.04, a P/E/G ratio of 2.53 and a beta of 1.50. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The company has a 50-day moving average of $159.52 and a 200 day moving average of $173.36.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, General Counsel Philip Mazzara sold 4,849 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total value of $600,306.20. Following the transaction, the general counsel directly owned 138,084 shares in the company, valued at $17,094,799.20. The trade was a 3.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 389,792 shares of company stock valued at $56,013,809 in the last quarter. Insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on ALAB shares. Raymond James Financial began coverage on Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price on the stock. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $192.89.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.